Company Filing History:
Years Active: 2023
Title: Zheng Yang: Innovator in Cancer Treatment
Introduction
Zheng Yang is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Zheng Yang holds a patent for the treatment of cancer with anti-GITR agonist antibodies. This patent outlines methods for treating cancer by administering a therapeutically effective amount of an anti-GITR antibody, either alone or in combination with an anti-PD-1 or anti-PD-L1 antibody. His work represents a promising advancement in cancer therapy.
Career Highlights
Zheng Yang is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His role in the company has allowed him to focus on groundbreaking research aimed at improving cancer treatment options.
Collaborations
Zheng has collaborated with esteemed colleagues, including Suba Krishnan and Penny E. Phillips. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer therapies.
Conclusion
Zheng Yang's contributions to cancer treatment through his patent and work at Bristol-Myers Squibb Company highlight his dedication to advancing medical science. His innovative approaches are paving the way for more effective cancer therapies.